home / stock / imrn / imrn quote
Last: | $2.47 |
---|---|
Change Percent: | 2.49% |
Open: | $2.45 |
Close: | $2.41 |
High: | $2.47 |
Low: | $2.42 |
Volume: | 5,978 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.47 | $2.45 | $2.41 | $2.47 | $2.42 | 5,978 | 04-18-2024 |
$2.41 | $2.4 | $2.41 | $2.42 | $2.4 | 1,301 | 04-17-2024 |
$2.4 | $2.5 | $2.4 | $2.58 | $2.1502 | 51,072 | 04-16-2024 |
$2.59 | $2.74 | $2.59 | $2.74 | $2.57 | 8,199 | 04-15-2024 |
$2.65 | $2.82 | $2.65 | $2.83 | $2.65 | 12,093 | 04-12-2024 |
$2.8514 | $2.88 | $2.8514 | $2.89 | $2.8001 | 11,169 | 04-11-2024 |
$2.99 | $2.95 | $2.99 | $3.09 | $2.82 | 92,326 | 04-10-2024 |
$2.755 | $2.795 | $2.755 | $2.89 | $2.7 | 51,884 | 04-09-2024 |
$2.72 | $2.65 | $2.72 | $2.8 | $2.65 | 21,266 | 04-08-2024 |
$2.645 | $2.62 | $2.645 | $2.6801 | $2.61 | 11,924 | 04-05-2024 |
$2.66 | $2.68 | $2.66 | $2.69 | $2.63 | 8,449 | 04-04-2024 |
$2.71 | $2.73 | $2.71 | $2.79 | $2.67 | 10,971 | 04-03-2024 |
$2.7 | $2.75 | $2.7 | $2.786 | $2.65 | 31,541 | 04-02-2024 |
$2.61 | $2.55 | $2.61 | $2.68 | $2.55 | 30,407 | 04-01-2024 |
$2.63 | $2.74 | $2.63 | $2.7406 | $2.58 | 29,738 | 03-29-2024 |
$2.63 | $2.74 | $2.63 | $2.7406 | $2.58 | 29,738 | 03-28-2024 |
$2.78 | $2.77 | $2.78 | $2.8 | $2.6801 | 17,812 | 03-27-2024 |
$2.7606 | $2.63 | $2.7606 | $2.8 | $2.63 | 32,134 | 03-26-2024 |
$2.6101 | $2.6 | $2.6101 | $2.7789 | $2.6 | 33,304 | 03-25-2024 |
$2.57 | $2.53 | $2.57 | $2.64 | $2.52 | 22,691 | 03-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Immuron Limited Company Name:
IMRN Stock Symbol:
NASDAQ Market:
MELBOURNE, Australia, April 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated b...
MELBOURNE, Australia, April 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Chief Executive Officer, Steven Lydeamore together with our Chief Scientific Officer, Dr. Jerry Kanello...
Shares of Ascent Solar Technologies, Inc. (NASDAQ: ASTI) fell sharply during Wednesday’s session after the company announced pricing of a $6...